Detalhe da pesquisa
1.
High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss.
Eur Respir J
; 57(1)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32703777
2.
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.
Emerg Infect Dis
; 26(11): 2709-2712, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32917293
3.
Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis.
Eur Respir J
; 55(3)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31862767
4.
Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study.
Eur Respir J
; 58(5)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34446465
5.
High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.
Am J Respir Crit Care Med
; 201(12): 1578-1579, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130864
6.
High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin.
Int J Infect Dis
; 133: 78-81, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37150352
7.
Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study.
Int Health
; 15(3): 258-264, 2023 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35420123
8.
Treatment outcomes for multidrug- and rifampicin-resistant tuberculosis in Central and West Africa: a systematic review and meta-analysis.
Int J Infect Dis
; 124 Suppl 1: S107-S116, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36007688
9.
Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation.
Trials
; 23(1): 1011, 2022 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36514153
10.
Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study.
J Bras Pneumol
; 48(2): e20220087, 2022.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-35475873
11.
Multidrug-resistant patients receiving treatment in Niger who are infected with M. tuberculosis Cameroon family convert faster in smear and culture than those with M. tuberculosis Ghana family.
Tuberculosis (Edinb)
; 122: 101922, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275231
12.
Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements.
Respir Med
; 161: 105844, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32056722
13.
Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study / Medidas de confinamento específicas de cada país em resposta à pandemia de COVID-19 e seu impacto no controle da tuberculose: um estudo global
J. bras. pneumol
; 48(2): e20220087, 2022. tab
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1375735